Cardiovascular Effects of Current and Future Anti-Obesity Drugs

E-ISSN： 1875-6212|12|3|493-504

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.12, Iss.3, 2014-01, pp. : 493-504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia

Current Vascular Pharmacology, Vol. 8, Iss. 6, 2010-11 ,pp. : 820-830

Bentham Science Publishers

Access to resources Recommend Favorite

Current Opinion in anti-parasitic drugs

By Keenihan S.H.

Trends in Parasitology, Vol. 17, Iss. 3, 2001-03 ,pp. : 120-120

Elsevier

Access to resources Recommend Favorite

Obesity Pharmacotherapy: Current Perspectives and Future Directions

Current Cardiology Reviews, Vol. 9, Iss. 1, 2013-02 ,pp. : 33-54

Bentham Science Publishers

Access to resources Recommend Favorite

Is there a future role for anti-TNF therapy in cardiovascular disease?

By Jacobsson Lennart TH Jovinge Stefan Turesson Carl

Future Rheumatology, Vol. 2, Iss. 3, 2007-06 ,pp. : 265-269

Future Medicine

Access to resources Recommend Favorite

Current and Future Applications of SAGE to Cardiovascular Medicine

By Patino W.D. Mian O.Y. Shizukuda Y. Hwang P.M.

Trends in Cardiovascular Medicine, Vol. 13, Iss. 4, 2003-05 ,pp. : 163-168

Elsevier

Access to resources Recommend Favorite